![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||||||||||||||
Michael Entzeroth, Ph.D. | ||||||||||||||||||||||
![]() |
||||||||||||||||||||||
![]() |
||||||||||||||||||||||
![]() |
||||||||||||||||||||||
Address: 91 Tanglin Halt Road, #31-300 Singapore 142091 / Singapore Occupation: since 2007: Senior Vice President (Drug Discovery), Experimental Therapeutics Centre, Singapore since 2006: Managing Director, Pharma Resources Asia Pte Ltd, Singapore 2003-2006: Chief Scientific Officer, S*BIO Pte Ltd, Singapore 1999-2002: Vice President Technology Development, CEREP SA, Rueil Malmaison / France 1994 - 1999: Head of High Throughput Screening (HTS), Boehringer Ingelheim Pharma KG, Biberach / Germany 1985 - 1993: Senior scientist in Biochemistry at the Boehringer Ingelheim subsidary Dr. Karl Thomae GmbH, Biberach / Germany Education: 1984 - 1985: Post-doc at Richard E. Moore, University of Hawaii 1975 - 1983: Study of Chemistry, University of Cologne, Ph.D. |
||||||||||||||||||||||
My Publications | ||||||||||||||||||||||
Medline | ||||||||||||||||||||||
Pharmaceutical Online | ||||||||||||||||||||||
Pharma Resources Asia | ||||||||||||||||||||||
![]() |
||||||||||||||||||||||